Challenges and Future Trends for Cancer Care in Egypt




The Land and Geography: Egypt is located in the northeastern corner of Africa. Rectangular in shape, it covers an area of 386,000 mile2. To the West lie the Western Desert and Libya, and the East is bordered by a desert plateau, Red Sea, Sinai, and Israel. The Sudan is on Egypt’s southern border and to the North lies the Mediterranean. Egypt can be divided into The Eastern Desert, The Western Desert, and The Nile Valley.

The people: Population (2012 est.): 83,688,164 (growth rate: 1.92 %. Cairo, 10,902,000, Alexandria, 4,387,000; Giza, 2,597,600 and the country is divided into 26 governorates. Poverty has declined over the past few decades; however, there is disparity—poverty in Upper Egypt increased from 29 to 34 % in rural areas and from 11 to 19 % in urban areas. Although Egypt has experienced a rapid transition to lower fertility, Egypt is the second most populous country in the WHO Eastern Mediterranean Region, with 43 % of the population living in urban areas and overcrowded conditions. The Egyptians are outgoing, warm, and have a distinct sense of humor. They have respect and a liking for foreigners, and a deep sense of tolerance for other races, religions, and nationalities [3].

Language: Arabic is Egypt’s official language. However, most Egyptians understand and speak English and French. In larger towns, the foreign visitor will encounter no difficulty in communicating with the people [4].

Religion: Approximately 85 % of the populations of Egypt are Moslems. Most of the balance, about nine million, is Christian Orthodox who belongs to the Coptic Church. In most cities in Egypt, mosques and churches can be found next to each other. There are also some synagogues since a small Jewish community still lives in Egypt [4].

Economy: Egypt is classified as a lower-middle-income country; however, characteristics of high-income, middle-income, and low-income countries coexist. Poverty has declined over the past few decades; however, there is disparity—poverty in Upper Egypt increased from 29 to 34 % in rural areas and from 11 to 19 % in urban areas [4].

The structure of the Egyptian Government is a democracy in transition, having recently elected a president; with all political authority is vested in the Government in Cairo [4].

The Egyptian health system: The health care system in Egypt is quite complex with a large number of public entities involved in the management, financing, and provision of care. Egypt’s wide network of public (several ministries beside the military and police), NGO, faith-based charity organizations, and private health facilities allow good geographic accessibility and coverage. The Ministry of Health and Population is responsible for overall health and population policy as well as the provision of public health services, and is responsible for health insurance organization that provides services too. The Ministry of higher education is however responsible for health profession education (medical, nursing, dentistry, and pharmacy) and also runs university teaching hospitals. Public health expenditure is low and has pluralistic and complex financing mechanisms: tax-based financing, health insurance, and fee for service through out-of-pocket expenditures. To achieve universal coverage, Egypt is rolling out a new insurance scheme, currently being piloted in Suez Governorate, based on a “family physician model” which will separate financing from service provision. Despite Government’s efforts for universal coverage, about half of total health expenditure comes from out-of-pocket (50 %) at the point of service in public and private facilities. Egypt produces over 90 % of the pharmaceuticals it consumes. Pharmaceuticals account for just over one-third of all health spending, of which approximately 85 % is private expenditure. Publicly produced medicines are heavily subsidized, which to a considerable extent accounts for their overuse [4, 5].

The Egyptian constitution enshrines free medical care as a basic right for all citizens, and though access to primary health care is fairly widespread, this ideal has yet to be fully realized. Vaccination rates, a good indicator of the access to basic health services, are high, and Egypt has also achieved some success in controlling communicable diseases. However, access to even basic services varies widely according to gender, region of residence, and socioeconomic status [4, 5].

The organization of the Egyptian health system is fairly complex. Public health care is highly centralized within the Ministry of Health and Population (MOHP), though a number of other public entities are involved in managing and financing health care services. The most important of these are the Health Insurance Organization (HIO), which finances and provides services to almost half the population, and the Ministry of Higher Education (MOHE), which is responsible for medical education and some service delivery (i.e., in university hospitals). There is no overarching institutional oversight of all public entities involved in providing health services, limiting coordination between the various branches [4, 5].

Expenditure on health: is divided in the following manner: 36 % goes to pharmaceuticals, 19 % to services provided by the MOHP, 18 % to the private sector, 10 % to university hospitals, 8 % to services provided by the insurance system, 6 % to NGOs, and 3 % to other public institutions. Private insurance is fairly limited in Egypt, as premiums are low and companies find it hard to turn a profit. Recent reforms have de-regulated premiums, making the regulatory environment somewhat less restrictive, but still difficult to operate in [4, 5].



Magnitude of Cancer Care in Egypt



The Demographic Profile of Egypt




1.

Population trends

(a)

The population size of Egypt

Currently, Egypt is experiencing significant size, age structure changes that will have major implications for its socioeconomic development. The population size of Egypt increased from 44.9 million in 1980 to approximately 78.1 million in 2010. It is projected that in 2050, the population size of Egypt will reach approximately 121.8 million.

 

(b)

Population growth in Egypt

The growth rate of the population of Egypt has been decreasing since the period 1980–1985, where it stood at 2.28 %. It reached 1.56 % in the period 1995–2000 and slightly increased afterwards to 1.68 % in the period 2005–2010. The population growth rate is expected to continue declining and will reach 0.69 % in the period 2045–2050.

 

 

2.

Indicators of demographic transition

(a)

Mortality transition in Egypt



  • Life expectancy

    Life expectancy at birth in Egypt gained 10 years from the period 1980–1985 to the period 2005–2010, increasing from 59.9 to 69.9 years. It is expected to reach 77.3 years in 2045–2050.

 

 

3.

The population structure

(a)

Egypt’s population age composition

The proportion of the population under 15 years of age has been decreasing since 1980 and is estimated to continue declining to 2050. At the same time, the proportion of the working-age population (15–64) has been increasing since 1980. It is projected to reach 66.9 % in 2040 then it will decline to 65.9 % in 2050. The proportion of the elderly population (65+) has also been increasing and is expected to reach 12.3 % in 2050.

The age distributions in Egypt vary widely with major differences in the percentage of young and old as seen in Table 9.1. Hence, currently there is less cancer, but the expected change in demographics over the next 20–30 years is likely to result in an explosive increase in noncommunicable diseases such as cancer and heart disease [6].


Table 9.1
The most frequent cancers in Egypt estimated using the results of the National Population-Based Registry Program of Egypt 2008–2011













































































































Sex

The most frequent cancer site

%

Crude rate

ASR

Male

Liver

33.63

39.5

61.8

Bladder

10.71

12.6

21.1

Lunga

5.69

6.7

10.4

Non-Hodgkin lymphoma

5.48

6.4

8.8

Brainb

5.48

6.4

8.8

Prostate

4.27

5.0

9.3

Female

Breast

32.04

35.8

48.8

Liver

13.54

15.1

24.4

Brainb

5.18

5.8

8.0

Ovary

4.12

4.6

6.3

Non-Hodgkin lymphoma

3.80

4.2

6.1

Thyroid

3.28

3.7

4.3

Both sexes

Liver

23.81

27.5

43.6

Breast

15.41

17.8

24.3

Bladder

6.94

8.0

13.5

Brainb

5.29

6.1

8.5

Non-Hodgkin lymphoma

4.64

5.4

7.5

Lunga

4.22

4.9

7.5


aIncludes trachea, bronchus, and lung tumors

bIncludes brain and nervous system tumors

Amal S. Ibrahim et al. [1]

 

(b)

Changing age structure

In 1950, the pyramid had a wide base signaling the structure of a young population. In 2050, the pyramid is expected to narrow down [6].

A327899_1_En_9_Figb_HTML.gif

 

(c)

Egypt’s youth population

In 1980, youth aged 15–24 years constituted 19.4 % of the total population and 35.16 % of the working-age population. In 2005, the percentage of youth increased to reach 21.1 % of the total population then started decreasing and is projected to reach 14.5 % in 2050 [6].

 

(d)

Egypt’s elderly population

The percentage of the elderly population (65+) in Egypt increased from 3.0 % in 1950 to 5.5 % in 2005 and remained as such in 2010. It is projected to continue increasing to reach 12.3 % in 2050 [6].

 

 


Current Status of Cancer Care in Egypt



An Overview and Profile of Frequent Cancers in Egypt


In men, liver and bladder cancers represented approximately 44 % of cancer in males.

In females, breast cancer occupied the top ranks accounting for 32.4 % of all cancers, followed by liver that accounting 13.54 %.

In both sexes, the proportions and rates of the most frequent cancer sites by gender, there was predominance of liver, breast, and bladder cancer that represented approximately 46 % of all cancers (Table 9.1).

During the period 2013–2050, population of Egypt is expected to increase to approximately 160 % the 2013 population size (Table 9.2). Applying the current age-specific incidence rates to successive populations would lead to a progressive increase in number of incident cases from 114,985 in 2013 to 331,169 in 2050, approximately 290 % of 2013 incidence (Table 9.3). This increase reflected both population growth and demographic change mainly due to aging of population. Population growth alone would increase the number of incident cases by 55.2 % in 2015. This fraction progressively decreased to become 32.8 % in 2050. The fraction due to aging gradually increased to reach 67.2 % in 2050 (Figs. 9.1, 9.2, 9.3, and 9.4).


Table 9.2
Incidence rates of cancer in Egypt (/100,000 populations) classified by region and sex for all cancer sites with and without nonmelanoma skin cancer (C44)

















































































































































































 
Male

Female

All

Male:female ratio
 
Crude rate

ASR

Crude rate

ASR

Crude rate

ASR

Crude rate

ASR
 
(95 % CI)

(95 % CI)

(95 % CI)

(95 % CI)

(95 % CI)

(95 % CI)

All sites

(i) Upper Egypt

97.1

142.8

116.9

167.1

107.0

155.0

0.8:1

0.9:1

(89.1–105.8)

(133.1–153.2)

(108.1–126.5)

(156.5–178.4)

(101.0–113.3)

(147.7–162.6)

(ii) Middle Egypt

109.7

170.0

95.9

132.1

102.9

151.1

11:1

13:1

(105.4–114.1)

(164.7–175.5)

(91.1–100.2)

(127.4–137.0)

(100.0–106.0)

(147.5–154.8)

(iii) Lower Egypt

138.5

191.8

131.7

173.3

135.2

182.6

11:1

11:1

(133.2–144.0)

(185.6–198.2)

(126.5–137.2)

(167.3–179.6)

(131.4–139.1)

(178.2–187.1)

(iv) Calculated rates of Egypt

117.3

178.5

111.7

159.1

114.5

169.0

11:1

11:1

(116.0–118.6)

(176.9–180.2)

(110.4–113.0)

(157.6–160.7)

(113.6–115.5)

(167.9–170.2)

All sites (excluding nonmelanoma skin cancer C44)

(i) Upper Egypt

96.0

141.0

115.1

163.9

105.5

152.5

0.8:1

0.9:1

(88.1–1104.6)

(131.4–151.4)

(106.3–124.5)

(153.4–175.1)

(99.5–111.8)

(145.5–160.1)

(ii) Middle Egypt

108.0

167.2

94.9

130.7

101.6

149.0

11:1

13:1

(103.8–112.3)

(162.0–172.6)

(90.9–99.1)

(126.0–135.6)

98.7–104.6)

(145.5–152.6)

(iii) Lower Egypt

136.7

189.1

130.1

170.9

133.5

180.0

11:1

11:1

(131.5–142.2)

(182.9–195.5)

(124.8–135.5)

(164.9–177.1)

(129.7–137.3)

(175.7–184.4)

(iv) Calculated rates of Egypt

115.7

175.9

110.3

157.0

113.1

166.6

11:1

11:1

(114.4–117.0)

(174.3–177.5)

(109.0–111.6)

(155.4–158.5)

(112.2–114.0)

(165.5–167.8)



Table 9.3
Estimated cancer incidence in the period 2013–2050 and causes of increase



























































 
2013

2015

2020

2025

2050

Estimated population

85,294,388 (100 %)

88,487,396 (103.7 %)

96,260,017 (112.9 %)

103,742,157 (121.6 %)

137,872,522 (161.6 %)

Number of casesa

114,985

122,783 (106.8 %)

144,255 (125.5 %)

168,723 (146.7 %)

331,169 (288.0 %)

Increased cases from 2013b
 
7798 (6.8 %)

29,270 (25.5 %)

53,738 (46.7 %)

216,184 (188.0 %)

Increased cases due to population growthc
 
4303

14,783

24,869

70,880

Increased cases due to population structure changed
 
3494

14,487

28,869

145,304

% increase due to population growthe
 
55.20 %

50.50 %

46.28 %

32.79 %


aNumber of expected cases depending on 2013 rates of incidence

bNumber of increased cases from 2013 number of cases

cNumber of increased cases (from 2013) that is attributed to increase in population number (population growth)

dNumber of increased cases (from 2013) that is attributed to change in population structure (aging of population) and not to population growth

ePercentage of increased number of cases (from 2013) that can be attributed to population growth only (not due to change in population structure)

Amal S. Ibrahim et al. [1]


A327899_1_En_9_Fig1_HTML.gif


Fig. 9.1
Calculated age-specific incidence rates for liver cancer in Egypt 2008–2011


A327899_1_En_9_Fig2_HTML.gif


Fig. 9.2
Calculated age-specific incidence rates for breast cancer in Egypt 2008–2011


A327899_1_En_9_Fig3_HTML.gif


Fig. 9.3
Estimated number of cases in Egypt (2013–2050)


A327899_1_En_9_Fig4_HTML.gif


Fig. 9.4
Estimated number of cases in Egypt (2013–2050) and causes of the increase in cases


Cancer Care Facilities in Egypt


Egypt has more facilities for cancer treatment than any other country in Africa; however, many elements of cancer control strategy still need to be implemented or improved [7]. Cancer treatment facilities, in fact, include the biggest and more specialized center. In the Middle East is the National Cancer Institute (NCI) which is affiliated to Cairo University. NCI is carrying research, education, and clinical responsibilities and is considered the main reference in Egypt regarding cancer. Also, South Egypt Cancer Institute, Assiut University, Assiut, Egypt, 14 clinical oncology departments in the other public universities; ten cancer centers affiliated to the Ministry of Health in 12 governorates; 11 military cancer units that treat both civilian and military patients; oncology clinics at the hospitals run by the Egyptian Health Insurance Organization in most major cities; semi-private, NGO-operated cancer facilities; a charity-run Centre of Excellence of Pediatric Oncology in Cairo; and private-sector clinics and centers. In addition to surgery, most of these facilities have chemotherapy and radiotherapy capabilities (either linear accelerators or cobalt-60 units). Most centers have CT scanners and MRI machines, and the country has five PET-CT scanners [8].

According to the WHO survey, Egypt had an operational policy, strategy, or action plan for cancer in 2010. However, no structured national cancer control program as recommended by WHO is in place. Practical measures are needed for the optimum allocation of available resources to reduce the numbers of cancer cases and deaths and to improve quality of life for patients with cancer, through adoption of WHO recommendations [9].


Approaches to Cancer Control



Prevention and Early Detection of Cancer


Although screening by mammography has been accepted as the gold-standard to ensure early detection of BC, its cost–benefit ratio is still debated in the scientific community. It is important to keep in mind that even in the best screening settings, most deaths from breast cancer are not currently prevented by mammography screening. The latest reviews indicate a reduction of no more than 15 % in BC mortality rate after introduction of mammography screening in western countries. Recent studies suggest that screening by CBE could achieve a reduction of 52–88 % of this magnitude with a better cost-effectiveness ratio.

Whatever screening tool is used, screening programs are resource-demanding and heavy-to-implement health interventions. Downstaging programs are an appealing alternative when resources are scarce, and should be considered as the first option in regions where a majority of BC is diagnosed at late stage.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Oct 28, 2016 | Posted by in ONCOLOGY | Comments Off on Challenges and Future Trends for Cancer Care in Egypt

Full access? Get Clinical Tree

Get Clinical Tree app for offline access